"NOVO NORDISK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

01/07/1996

VAT status

Active

Bankruptcy proceedings

No proceedings

"NOVO NORDISK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contacts

Registered address

See on map

Website

Highest

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Incorporation date

18/02/2002

Share capital

9,021,000.00 PLN

Primary activity

Research and experimental development on natural sciences and engineering (72.10.Z - PKD 2007)

Representatives

Representatives rights

DO REPREZENTOWANIA SPÓŁKI UPRAWNIONY JEST KAŻDY CZŁONEK ZARZĄDU SAMODZIELNIE.

Representatives

No representatives

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

Person	Title
-	-

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

47,369,254

Net Profit (zł)

47,369,254

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2022
234,179,491
13,752,485
9,660,912
0.20
2.01
4.13
41,479,289
46,390,928
0
2,134,682

2023
327,143,263
20,259,236
14,888,626
0.22
2.15
4.55
56,367,915
63,509,497
0
2,390,697

2024
413,995,330
24,635,041
47,369,254
0.31
2.90
11.44
103,737,169
67,115,378
0
-

2024
413,995,330
24,635,041
47,369,254
0.31
2.90
11.44
103,737,169
67,115,378
0
-

Turnover (zł)

2024

Turnover (zł)

413,995,330 zł27 % *

Profit before tax (zł)

24,635,041 zł22 % *

Net Profit (zł)

47,369,254 zł218 % *

Working capital requirement (%)

0.31 40.91 % *

Liquidity ratio

2.90 34.88 % *

Net profitability (%)

11.44 %151.43 % *

Equity (zł)

103,737,169 zł84 % *

Current liabilities (zł)

67,115,378 zł6 % *

Non current liabilities (zł)

0 zł- *

Non-current Assets (zł)

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Price: 1.00 credit

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

"NOVO NORDISK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents

Date	Description
12/06/2025	OD 01.01.2024 DO 31.12.2024
26/06/2024	OD 01.01.2023 DO 31.12.2023
06/06/2023	OD 01.01.2022 DO 31.12.2022
31/08/2022	OD 01.01.2021 DO 31.12.2021
01/07/2021	OD 01.01.2020 DO 31.12.2020